@MarkC53916729 @DewDiligence $VIR proposed P-2 study (VIR-2218 +pegIFN) maybe attempting to activate more immunity to lower HBsAg levels? Guessing they are looking for an immune-modulator to speed things up. Systemic side-effect associated with pegIFN seems differentiated to $JNJ + $ARWR approach.